Trade Amgen ^AMGN

ProShare Advisors LLC Sells 158,994 Shares of Amgen Inc. $AMGN

Amgen Reshapes Inflammation Portfolio As Investors Weigh Cash And Pipeline Shifts

BioAsia lifesciences conclave

Bessemer Group Inc. Acquires 2,967 Shares of Amgen Inc. $AMGN

Amgen (Nasdaq:AMGN) - Stock Analysis - Simply Wall St

Equities Research Analysts' Downgrades for February 7th (ACNB, AIR, AMGN, ANIX, AOSL, APTV, ARAY, ARCC, ASTE, ASYS) - Daily Political

Twin Capital Management Inc. Sells 5,541 Shares of Amgen Inc. $AMGN

Renaissance Group LLC Lowers Position in Amgen Inc. $AMGN

Amgen (NASDAQ:AMGN) Given New $347.00 Price Target at Guggenheim - Daily Political

Jim Cramer Says Stocks Like Johnson & Johnson "Simply Refuse to Quit"

Amgen (AMGN) Receives a Buy from Argus Research | Markets Insider

Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock

Amgen (NASDAQ:AMGN) Price Target Raised to $347.00

Amgen (NASDAQ:AMGN) Price Target Raised to $295.00

Aurdan Capital Management LLC Sells 5,316 Shares of Amgen Inc. $AMGN - Markets Daily

3,190 Shares in Amgen Inc. $AMGN Acquired by ABN AMRO Bank N.V.

Amgen Refocuses Portfolio As Eczema Exit And Tavneos Review Raise Questions

Top Medical Stocks To Add to Your Watchlist - February 4th - Stock Observer

RBC Lifts Amgen (AMGN) Target After Strong Q4, Cites Key Drug Momentum

Amgen Inc. $AMGN Shares Sold by Envestnet Asset Management Inc.

Is It Time To Reassess Amgen (AMGN) After Strong Recent Share Price Gains

Morgan Stanley Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - Daily Political

Dow Leads in Mixed Session on Amgen Earnings: Stock Market Today

Dow Climbs as Amgen Leads Blue-Chip Rebound; Tech Selloff Drags Nasdaq Lower

Stocks making the biggest moves midday: MGM, AMGN, AMD, ENPH

Cantor Fitzgerald Increases Amgen (NASDAQ:AMGN) Price Target to $350.00

Amgen (NASDAQ:AMGN) Sets New 1-Year High Following Strong Earnings

Morgan Stanley Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - Markets Daily

Withdraw Tavneos from market? Amgen tells FDA no | BioWorld

Amgen's Diversified Portfolio and Growing Cardiovascular Focus Support a Wide Moat | Morningstar

Morgan Stanley Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock

The Goldman Sachs Group Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price

Royal Bank Of Canada Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock

Leerink Partners Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - Markets Daily

Amgen (NASDAQ:AMGN) Price Target Raised to $355.00

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and BeOne Medicines (ONC) | Markets Insider

Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation - Simply Wall St News

The Goldman Sachs Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - Daily Political

Amgen (NASDAQ:AMGN) Stock Unloaded Rep. David Taylor

Rep. David Taylor Buys Shares of Amgen Inc. (NASDAQ:AMGN)

Amgen thumbs-down on FDA's ask, Tavneos sales continue | BioWorld

Amgen ends Rocatinlimab collaboration with Japan's Kyowa Kirin

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Amgen (NASDAQ:AMGN) Issues Earnings Results - Markets Daily

Amgen (NASDAQ:AMGN) Releases Earnings Results, Beats Expectations By $0.53 EPS - Markets Daily

Amgen Q4 Earnings Call Highlights | MarketBeat

Amgen (NASDAQ:AMGN) Updates FY 2026 Earnings Guidance

Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.55 EPS

Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025

Amgen sees FY26 CapEx $2.6B; share repurchases not to exceed $3B | Markets Insider

Amgen sees FY26 adjusted EPS $21.60-$23.00, consensus $22.14 | Markets Insider

Amgen reports Q4 adjusted EPS $5.29, consensus $4.76 | Markets Insider

Amgen quarterly results beat Street estimates on higher sales, lower tax rate

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS | Morningstar

Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets

Amgen options imply 3.4% move in share price post-earnings | Markets Insider

Amgen Inc. Q4 Profit Rises

Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline"

Amgen Q4 25 Earnings Conference Call At 4:30 PM ET

AlphaQuest LLC Makes New Investment in Amgen Inc. $AMGN

Will Exiting Rocatinlimab Reshape Amgen's (AMGN) Immunology Focus and Broader R&D Narrative? - Simply Wall St News

Amgen News | Markets Insider

Steve Jobs' Son Enters Venture Capital Field, Raises $200M to Combat Cancer

AMGN: Obesity And Cardiovascular Pipeline Will Shape Long-Term Cash Generation

Regulatory clarity lifts Aquestive despite CRL for Anaphylm | BioWorld

Principal Financial Group Inc. Lowers Holdings in Amgen Inc. $AMGN

United Community Bank Sells 3,842 Shares of Amgen Inc. $AMGN

Amgen quits Kyowa Kirin deal, returns rocatinlimab | BioWorld

Kyowa Kirin (TSE:4151) Regains Rocatinlimab Control Is Its R&D Strategy Entering a New Phase? - Simply Wall St News

Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings

Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook

Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN

Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities - Simply Wall St News

Alpha Cubed Investments LLC Reduces Holdings in Amgen Inc. $AMGN

Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views

Amgen (NASDAQ:AMGN) Reaches New 1-Year High - Should You Buy? - Stock Observer

IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight

UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves

Amgen Inc. $AMGN Shares Sold by New York State Common Retirement Fund

AE Wealth Management LLC Purchases 18,798 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by JSF Financial LLC - Daily Political

Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - Daily Political

Amgen Inc. $AMGN Stake Increased by Fidelis Capital Partners LLC - Daily Political

Amgen Faces 340B Legal Challenge As Stock Trades Near Analyst Views

Amgen (NASDAQ:AMGN) Sets New 12-Month High - What's Next?

Amgen Inc. $AMGN is Federated Hermes Inc.'s 10th Largest Position

Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp

Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains

Amgen (AMGN) to Release Quarterly Earnings on Tuesday

Bernstein Calls 2026 a "Waiting Year" for Amgen's (AMGN) MariTide

Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN - Daily Political

15 Best S&P 500 Dividend Stocks to Buy in 2026

Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

The Week Ahead: ISM services, SMCI

Week ahead: RBA meeting, Uber earnings, and PMIs

Week ahead: Earnings season climax

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk